PULMONX CORPORATION — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↓-4.9% -$1M
$23M
Cost of Revenue↓-18.1% -$1M
$5M
Gross Profit↓-0.3% -$49K
$18M
R&D↑+14.5% +$582K
$5M
SG&A↓-15.3% -$4M
$23M
D&A↑+200.0% +$200K
$300K
Operating Income↓-1.9% -$264K
$-14M
EBITDA↑+200.0% +$200K
$300K
Interest Expense↓-8.6% -$72K
$770K
Interest Income↓-56.7% -$592K
$453K
Other Income/Expense↑+477.1% +$959K
$758K
Pretax Income↑+0.9% +$123K
$-14M
Tax Provision↑+389.5% +$148K
$186K
Net Income↑+1.3% +$187K
$-14M
Gross Margin↑+3.6pts
77.6%
Operating Margin↑+2.4pts
-66.9%
Net Margin↑+4.5pts
-64.9%
Effective Tax Rate↑+0.5pts
-0.9%
Deferred Tax Liabilities
$22K
ETR (Continuing Operations)↓-0.3pts
-1.2%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+0.0pts
-0.1%
ETR Foreign Differential (pp)↑+0.3pts
0.4%
Operating Lease Cost↑+4.0% +$32K
$827K
Revenue YoY Variation↓-28.2pts
-4.9%
Income YoY Variation↓-8.8pts
-1.9%
Revenue QoQ Variation↓-11.5pts
5.1%
Income QoQ Variation↓-6.8pts
2.8%